Human CASP6/MCH2 ORF/cDNA clone-Lentivirus plasmid (NM_001226)
Cat. No.: pGMLP000521
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CASP6/MCH2 Lentiviral expression plasmid for CASP6 lentivirus packaging, CASP6 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
Caspase 6/p18/p11/CASP6/CASP6/MCH2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000521 |
| Gene Name | CASP6 |
| Accession Number | NM_001226 |
| Gene ID | 839 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 882 bp |
| Gene Alias | MCH2 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAGCTCGGCCTCGGGGCTCCGCAGGGGGCACCCGGCAGGTGGGGAAGAAAACATGACAGAAACAGATGCCTTCTATAAAAGAGAAATGTTTGATCCGGCAGAAAAGTACAAAATGGACCACAGGAGGAGAGGAATTGCTTTAATCTTCAATCATGAGAGGTTCTTTTGGCACTTAACACTGCCAGAAAGGCGGGGCACCTGCGCAGATAGAGACAATCTTACCCGCAGGTTTTCAGATCTAGGATTTGAAGTGAAATGCTTTAATGATCTTAAAGCAGAAGAACTACTGCTCAAAATTCATGAGGTGTCAACTGTTAGCCACGCAGATGCCGATTGCTTTGTGTGTGTCTTCCTGAGCCATGGCGAAGGCAATCACATTTATGCATATGATGCTAAAATCGAAATTCAGACATTAACTGGCTTGTTCAAAGGAGACAAGTGTCACAGCCTGGTTGGAAAACCCAAGATATTTATCATTCAGGCATGTCGGGGAAACCAGCACGATGTGCCAGTCATTCCTTTGGATGTAGTAGATAATCAGACAGAGAAGTTGGACACCAACATAACTGAGGTGGATGCAGCCTCCGTTTACACGCTGCCTGCTGGAGCTGACTTCCTCATGTGTTACTCTGTTGCAGAAGGATATTATTCTCACCGGGAAACTGTGAACGGCTCATGGTACATTCAAGATTTGTGTGAGATGTTGGGAAAATATGGCTCCTCCTTAGAGTTCACAGAACTCCTCACACTGGTGAACAGGAAAGTTTCTCAGCGCCGAGTGGACTTTTGCAAAGACCCAAGTGCAATTGGAAAGAAGCAGGTTCCCTGTTTTGCCTCAATGCTAACTAAAAAGCTGCATTTCTTTCCAAAATCTAATTAA |
| ORF Protein Sequence | MSSASGLRRGHPAGGEENMTETDAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSN |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T20600-Ab | Anti-CASP6 monoclonal antibody |
| Target Antigen | GM-Tg-g-T20600-Ag | CASP6 protein |
| ORF Viral Vector | pGMLP000521 | Human CASP6 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000234 | Human CASP6 Adenovirus plasmid |
| ORF Viral Vector | vGMLP000521 | Human CASP6 Lentivirus particle |
| ORF Viral Vector | vGMAP000234 | Human CASP6 Adenovirus particle |
Target information
| Target ID | GM-T20600 |
| Target Name | Caspase 6/p18/p11/CASP6 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
839 |
| Gene ID |
100072861 (Equus caballus), 12368 (Mus musculus), 487899 (Canis lupus familiaris), 538409 (Bos taurus) 698788 (Macaca mulatta), 83584 (Rattus norvegicus), 839 (Homo sapiens) |
| Gene Symbols & Synonyms | CASP6,Casp6,Mch2,CASP-6,MCH2,CSP-6,caspase-6 |
| Target Alternative Names | Apoptotic protease Mch-2,CASP-6,CASP6,CSP-6,Casp6,Caspase 6,Caspase-6,MCH2,Mch2,caspase-6,p11,p18 |
| Uniprot Accession |
O08738,O35397,P55212,Q3T0P5
Additional SwissProt Accessions: O08738,Q3T0P5,O35397,P55212 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | Apoptosis, Lipid and atherosclerosis |
| Gene Ensembl | ENSECAG00000015479, ENSMUSG00000027997, ENSBTAG00000012537, ENSMMUG00000008174, ENSG00000138794 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


